Quarterly Report • May 10, 2023
Quarterly Report
Open in ViewerOpens in native device viewer
| in EUR million | 1-3 2023 | Change | 1-3 2022 | 2022 |
|---|---|---|---|---|
| Revenue | 185.2 | 2.0% | 181.5 | 779.8 |
| EBITDA | 20.8 | 2.7% | 20.3 | 100.5 |
| EBITDA margin | 11.2% | +0.1 PP | 11.2% | 12.9% |
| EBIT | 13.2 | 4.2% | 12.7 | 62.1 |
| EBIT margin | 7.1% | +0.1 PP | 7.0% | 8.0% |
| Earnings after taxes | 8.3 | 13.2% | 7.3 | 38.4 |
| Earnings per share (EPS)1 , in EUR |
0.02 | –96.7% | 0.75 | 11.99 |
| Gross cash flow | 10.1 | –65.8% | 29.6 | 38.4 |
| Return on equity2 | 0.4% | –10.7 PP | 11.1% | 45.7% |
| in EUR million | 31.03.2023 | Change | 31.3.2022 | 31.12.2022 |
|---|---|---|---|---|
| Total assets | 847.6 | –15.0% | 996.7 | 842.9 |
| Equity | 518.0 | –7.6% | 560.4 | 518.2 |
| Equity ratio | 61.1% | +4.9 PP | 56.2% | 61.5% |
| Additions to intangible assets and property, plant and equipment |
||||
| 5.4 | –46.3% | 10.0 | 50.1 | |
| Employees (at reporting date) | 6,510 | –7.1% | 7,007 | 6,528 |
| in EUR million | 1-3 2023 | Change | 1-3 2022 | 2022 |
|---|---|---|---|---|
| Industrial Sector = Semperflex + Semperseal + Sempertrans + Semperform | ||||
| Revenue | 176.4 | 3.2% | 171.0 | 734.0 |
| EBITDA | 30.6 | 15.7% | 26.4 | 125.2 |
| EBIT | 23.7 | 20.6% | 19.6 | 95.9 |
| Semperflex | ||||
| Revenue | 72.6 | –9.0% | 79.8 | 328.8 |
| EBITDA | 16.7 | –14.6% | 19.6 | 82.2 |
| EBIT | 13.6 | –18.1% | 16.6 | 70.2 |
| Semperseal | ||||
| Revenue | 32.0 | –12.7% | 36.6 | 142.1 |
| EBITDA | 1.6 | –33.1% | 2.4 | 8.3 |
| EBIT | 0.0 | –98.9% | 0.5 | –0.6 |
| Sempertrans | ||||
| Revenue | 43.0 | 52.0% | 28.3 | 151.9 |
| EBITDA | 7.3 | >100% | 1.3 | 19.7 |
| EBIT | 6.2 | >100% | 0.3 | 15.5 |
| Semperform | ||||
| Revenue | 28.8 | 9.8% | 26.2 | 111.1 |
| EBITDA | 5.0 | 54.3% | 3.2 | 15.1 |
| EBIT | 3.9 | 79.7% | 2.1 | 10.8 |
| Medical Sector = Sempermed | ||||
| Revenue | 39.6 | –62.7% | 106.1 | 324.2 |
| EBITDA | –11.6 | n/a | 13.3 | –15.4 |
| EBIT | –13.5 | n/a | 7.6 | –49.5 |
Note: Rounding differences in the totalling of rounded amounts and percentages may arise from the use of automatic data processing. 1 Earnings per share are only attributable to the core shareholders of Semperit AG Holding (excl. remuneration from hybrid capital). 2 Based on a full-year projection.
In the first quarter of 2023, the Semperit Group recorded an improvement in its continued operations despite the onset of an economic slowdown. The result of the discontinued operations declined significantly in line with expectations.
During the first three months, prices for natural rubber (important especially for Sempertrans) and natural latex (important for Sempermed) were significantly lower than in the comparable period of last year (natural rubber –24% and natural latex –18%) on the relevant Asian commodity exchanges.
The average prices for the essential basic raw material butadiene, which is relevant for all segments, were slightly higher in Asia (+2%) and lower in Europe (–9%) in the first quarter of 2023 compared to the same period of the previous year. However, the prices of butadiene derivatives such as butadiene rubber, styrene butadiene rubber and nitrile butadiene rubber did not decrease accordingly due to the energy surcharges still included.
In the first quarter of 2023, prices for nitrile latex, the most important raw material for Sempermed, were significantly below the comparable level of last year due to a continued decline in market demand and despite slightly higher Asian butadiene prices.
Generally, the price trend of heavy fuel oil (HFO), which strongly correlates with the general crude oil price development, is a relevant indicator for the filler carbon black, which is used in the entire Industrial Sector. However, other factors (energy and CO2 surcharges and above all the war in Ukraine) have had a significant impact on carbon black prices in the last 12 months. While in the first quarter of 2023, the average HFO price was 24% lower than in the first quarter of 2022, carbon black prices were very significantly higher than in the same period of the previous year. The increase was caused by the energy and CO2 surcharges on the one hand and, on the other hand especially by the significant drop in carbon black imports into the EU from Russia (–50%) and the discontinuation of imports from Ukraine as well as due to the announced EU sanctions for 2024.
Prices for wire rod – a raw material relevant for the Semperflex, Sempertrans and Semperform segments – decreased by up to 30% after the record levels in the second quarter of 2022 but are still above the five-year average. This development was, on the one hand due to energy prices and, on the other hand, to the current global cooling of the economy and low demand, which led to high inventories of finished and semi-finished materials.
The price of iron ore, the raw material for wire rod, reflects the low demand – especially from China – and declined by 25% year-on-year.
| in EUR million | 1-3 2023 | Change | 1-3 2022 |
|---|---|---|---|
| Revenue | 185.2 | +2.0% | 181.5 |
| EBITDA | 20.8 | +2.7% | 20.3 |
| EBITDA margin | 11.2% | +0.1 PP | 11.2% |
| EBIT | 13.2 | +4.2% | 12.7 |
| EBIT margin | 7.1% | +0.1 PP | 7.0% |
| Earnings after tax from continued operations | 8.3 | +13.2% | 7.3 |
| Earnings after tax from discontinued operations | –7.9 | n/a | 8.2 |
| Earnings after taxes | 0.4 | –97.4% | 15.5 |
| Additions to intangible assets and property, plant and | |||
| equipment | 5.4 | –46.3% | 10.0 |
| Employees (at reporting date) | 6,510 | –7.1% | 7,007 |
In the first quarter of 2023, the continued operations of the Semperit Group recorded an increase in revenue of +2.0% to EUR 185.2 million compared to the previous year. Revenue in the Industrial Sector increased by +3.2% to EUR 176.4 million, whereas revenue from continued operations in the Medical Sector (in Wimpassing and Sopron) decreased by –16.9% to EUR 8.8 million. The increase in revenue compared to Q1 2022 was mainly driven by the increase in average selling prices in the course of 2022 resulting in average price effect on revenues at 19% in the Industrial Sector – the price effect being in a range between 15% and 29% for the individual segments – thus input factor price increases could be passed on. The volume increase at Sempertrans (+23.0%) is largely attributable to a positive market environment in the mining industry and higher demand. Sales volumes in the other segments fell significantly; at Semperflex, this decline was mainly due to full inventories held by most customers, while in the Semperform segment it was mainly the Engineered Solutions business unit (driven by reduced market activity in the railroad superstructure sector), which fell short of the previous year's figures. Semperseal recorded a significant decline in sales volumes resulting from the weak development of the construction sector.
Inventories of own products of continued operations increased by EUR 7.1 million during the first threee months of the year (1-3 2022: increase of EUR 11.7 million).
Cost of materials (including energy and purchased services) in continued operations decreased by EUR 5.9 million or –5.8% to EUR 96.2 million in the first quarter of 2023. The change was largely due to low production volumes in the Semperflex, Semperseal and Semperform segments, which was offset by the increased production volumes at Sempertrans. Increases in raw material and energy prices also had a counteracting effect, although these were more than offset by lower volumes.
Personnel expenses rose to EUR 52.7 million (+5.7%) in the first quarter of 2023, driven mainly by wage and salary increases that became effective in 2022.
At EUR 24.4 million, other operating expenses were up by +9.5% compared to the same period of the previous year (1-3 2022: EUR 22.3 million). The increase is mainly attributable to expenses from strategic corporate development projects – in particular in connection with the signing of the purchase and assignment agreement for the acquisition of the RICO Group. In addition higher maintenance costs and increased travel costs as business travel picked up again after the corona pandemic were recorded.
At EUR 20.8 million, EBITDA in continued operations largely remained unchanged. The EBITDA margin in continued operations was 11.2% (1-3 2022: 11.2%).
In the first quarter of the year depreciation and amortisation in continued operations remained unchanged at EUR 7.6 million (1-3 2022: EUR 7.6 million). At EUR 13.2 million, EBIT of continued operations also remained on the level of the same period of the previous year.
The financial result of continued operations amounted to EUR –1.9 million (1-3 2022: EUR –2.0 million).
Tax expense in continued operations amounted to EUR 2.9 million (1-3 2022: EUR 3.3 million). In the first quarter of 2023, the effective tax rate of continued operations was 24.1% compared to 27.5% in the same period of the previous year. Here, the effective tax rate refers to income taxes in relation to earnings before tax less profit or loss attributable to redeemable non-controlling interests.
Earnings after tax from continued operations were EUR 8.3 million (1-3 2022: EUR 7.3 million). Earnings after tax from discontinued operations amounted to EUR –7.9 million (1-3 2022: EUR 8.2 million). Further details on discontinued operations will follow in the next chapter.
Earnings after tax (continued and discontinued operations together) amounted to EUR 0.4 million (previous year: EUR 15.5 million). Earnings per share attributable to the shareholders of Semperit AG Holding for the first quarter of 2023 were therefore EUR 0.02 (1-3 2022: EUR 0.75).
Revenue from discontinued operations decreased to EUR 39.6 million during the first three months of 2023 (1-3 2022: EUR 106.1 million), particularly due to the end of the corona-related special cycle. Nearly 75% of the decline in sales is attributable to lower average selling prices (ASPs) for gloves.
In discontinued operations, the cost of materials was EUR 36.0 million and thus 42% lower than in the previous year (1-3 2022: EUR 62.2 million) due to lower production volumes and low raw material prices. As pre-packaged surgical gloves are currently, and will continue to be, sold by Semperit Technische Produkte GmbH to Semperit Investments Asia Pte Ltd (currently still part of the Group), which then sells the products of the Sempermed segment to internal and external customers, the cost of materials (of the discontinued operations) amounting to EUR 8.8 million from this supply relationship as a result of the contract manufacturing agreement is included in the cost of materials of the discontinued operations. Personnel expenses decreased by EUR 1.7 million, or 18%, to EUR 7.4 million as a result of the reduction in temporary workers and the reduction in vacation accruals. The 52% decline in other operating expenses to EUR 5.2 million was attributable to the significant drop in freight costs.
As expected, EBITDA in the discontinued operations of the Medical Sector thus decreased significantly from EUR 16.3 million to EUR –9.0 million.
Due to the signing of the SPA with HARPS GLOBAL PTE. LTD., it was possible to determine a fair value for the segment assets of Sempermed as of March 31, 2023 based on the selling price (cash and debt free) and taking into account the price adjustment mechanism provided for in the SPA. Directly attributable disposal costs still expected to be incurred were to be deducted from this. The resulting reversal of impairment losses on the assets of the discontinued operation totaled EUR 1.1 million as of March 31, 2023.
EBIT in the discontinued operations of the Medical Sector fell significantly from EUR 11.0 million to EUR –8.0 million.
The following table shows the results based on segment reporting. The segmentation by business areas is based on internal management and reporting and also includes the Sempermed segment as a whole.
This "as-if" presentation shows the figures as if the separation into continued and discontinued operations had not taken place. The earnings figures take into account the continued and discontinued operations as well as all consolidation entries necessary at Group level.
| in EUR million | 1-3 2023 | Change | 1-3 2022 |
|---|---|---|---|
| Revenue | 216.0 | –22.0% | 277.0 |
| EBITDA | 11.7 | –68.0% | 36.5 |
| EBITDA margin | 5.4% | –7.8 PP | 13.2% |
| EBIT | 2.5 | –89.6% | 23.7 |
| EBIT margin | 1.1% | –7.5 PP | 8.6% |
At the 134th Annual General Meeting of Semperit AG Holding (the "Company") held on 25 April 2023, the distribution of a basic dividend of EUR 1.50 per share plus a conditional additional dividend of EUR 3.00 per share was resolved for the 2022 financial year in accordance with the proposal of the Executive Board and the Supervisory Board of the Company under the following conditions: The entitlement to the additional dividend as well as the payment are subject to the conditions precedent that the conditions precedent for the sale of the medical business (Sempermed; initially production of examination gloves including sales organisation) are fulfilled by 16 September 2023, that the medical business has been transferred to the buyer by 31 October 2023, and that Semperit AG Holding has received the full purchase price payable on the day of this closing. Within 7 calendar days after the fulfilment of the above conditions, the Company will obtain a confirmation regarding the fulfilment of the conditions and, immediately after receipt of the confirmation, will announce in a supplementary dividend announcement whether the above conditions have been met. The supplementary dividend announcement will also contain the technical modalities of the supplementary dividend payment, whereby the supplementary dividend is to be paid within 21 calendar days after the fulfilment of the above conditions precedent if the conditions precedent are met. If the conditions precedent do not come into effect, the Company will announce this.
The development of the balance sheet structure as of 31 March 2023 can be summarised as follows:
| in EUR million | 31.03.2023 | Share | 31.12.2022 | Share | Change |
|---|---|---|---|---|---|
| Non-current assets | 320.9 | 38% | 316.6 | 38% | +1.4% |
| Current assets | 353.2 | 42% | 338.4 | 40% | +4.4% |
| Assets held for sale | 173.4 | 20% | 187.9 | 22% | –7.7% |
| ASSETS | 847.6 | 100% | 842.9 | 100% | +0.6% |
| Equity1 | 518.8 | 61% | 519.1 | 62% | –0.1% |
| Non-current provisions and liabilities |
116.7 | 14% | 115.9 | 14% | +0.7% |
| Current provisions and liabilities | 166.5 | 20% | 161.0 | 19% | +3.4% |
| Provisions and liabilities held for sale |
45.6 | 5% | 46.9 | 6% | –2.9% |
| EQUITY AND LIABILITIES | 847.6 | 100% | 842.9 | 100% | +0.6% |
1 including non-controlling interests
Non-current assets recorded only a slight change. Additions to non-current assets of EUR 6.3 million and a positive FX effect of EUR 2.4 million were mainly offset by write-downs of EUR 7.6 million.
Current assets have increased since 31 December 2022, due to a EUR 12.4 million rise in cash and cash equivalents and a EUR 7.0 million increase in trade receivables.
The increase in current liabilities and provisions resulted primarily from the increase in other provisions by EUR 4.1 million and in other financial liabilities by EUR 3.2 million.
As of 31 March 2023, the Semperit Group exhibited a net cash surplus of EUR 66.1 million, as cash and cash equivalents exceeded financial liabilities (31 December 2022: EUR 54.2 million). The calculated ratio between the net cash surplus (i.e., theoretical negative net indebtedness) and EBITDA as of 31 March 2023 was thus –0.8x (31 December 2022: –0.5x).
With effect from March 31, 2023, new bank financing agreements with a financing volume of up to EUR 360 million were concluded. A financing agreement totaling EUR 250 million consisting of a loan of up to EUR 150 million and a credit facility line of EUR 100 million. In this financing agreement, Semperit AG Holding has committed to compliance with three ESG KPIs, which are also part of the sustainability strategy "30 by 2030". This financing is provided by a group of six Austrian and international banks and replaces the former credit facility line in the amount of EUR 75 million. The second financing agreement in the amount of EUR 110 million was concluded in particular to finance the expansion investment in Odry.
The cash flow statement is prepared jointly for the continued and discontinued operations; no distinction is made between the cash flows of the individual business units. The cash flows from operating, investing and financing activities of the discontinued operation are disclosed in the notes.
The development of the liquidity situation in the first three months of 2023 can be summarised as follows:
| in EUR million | 1-3 2023 | Change | 1-3 2022 |
|---|---|---|---|
| Cash flows from operating activities | 21.1 | +20.0% | 17.5 |
| Cash flows from investing activities | –13.9 | –21.2% | –17.7 |
| Free cash flow | 7.1 | n/a | –0.1 |
| Cash flows from financing activities | –1.2 | –81.2% | –6.2 |
| Net increase / decrease in cash and cash equivalents | 5.0 | n/a | –4.4 |
| Cash and cash equivalents at the end of the period | 162.9 | –29.5% | 231.1 |
In the first quarter of 2023, cash flow from operating activities was higher than in the previous year despite the lower result, mainly thanks to the development of the balance from changes in inventories, trade receivables and trade payables, which was positive during the first three months 2023 and amounted to EUR 5.3 million (1-3 2022: funds tied up at EUR 27.3 million).
At EUR 14.5 million, cash expenditures in intangible assets and property, plant and equipment in in the first quarter of 2023 were below the prior-year level (1-3 2022: EUR 17.2 million). The largest investments were made in the Czech Republic with EUR 6.3 million (1-3 2022: EUR 1.5 million), Austria with EUR 3.3 million (1-3 2022: EUR 5.4 million), Germany with EUR 1.4 million (1-3 2022: EUR 0.8 million) and Poland with EUR 1.4 million (1-3 2022: EUR 1.2 million).
Free cash flow (the balance of cash flow from operating activities and cash flow from investing activities) was EUR 7.1; in the first quarter of 2022 it was EUR –0.1 million.
Cash flow from financing activities in the first quarter of 2023 included in particular the repayment of lease liabilities (EUR 1.0 million). In the comparative period, this item included the repayment of a current financial liability in Malaysia amounting to EUR 4.8 million.
| in EUR million | 1-3 2023 | Change | 1-3 2022 |
|---|---|---|---|
| Revenue | 176.4 | +3.2% | 171.0 |
| EBITDA | 30.6 | +15.7% | 26.4 |
| EBITDA margin | 17.3% | +1.9 PP | 15.5% |
| EBIT | 23.7 | +20.6% | 19.6 |
| EBIT margin | 13.4% | +1.9 PP | 11.5% |
| Additions to intangible assets and property, plant and equipment |
5.0 | +16.4% | 4.3 |
| Employees (at reporting date) | 3,756 | –3.2% | 3,881 |
Key figures Semperflex
| in EUR million | 1-3 2023 | Change | 1-3 2022 |
|---|---|---|---|
| Revenue | 72.6 | –9.0% | 79.8 |
| EBITDA | 16.7 | –14.6% | 19.6 |
| EBITDA margin | 23.0% | –1.5 PP | 24.5% |
| EBIT | 13.6 | –18.1% | 16.6 |
| EBIT margin | 18.8% | –2.1 PP | 20.8% |
| Additions to intangible assets and property, plant and equipment |
1.6 | +54.6% | 1.1 |
| Employees (at reporting date) | 1,710 | –6.7% | 1,834 |
• Continued low demand due to high inventories and destocking by customers.
Key figures Semperseal
| in EUR million | 1-3 2023 | Change | 1-3 2022 |
|---|---|---|---|
| Revenue | 32.0 | –12.7% | 36.6 |
| EBITDA | 1.6 | –33.1% | 2.4 |
| EBITDA margin | 5.0% | –1.5 PP | 6.5% |
| EBIT | 0.0 | –98.9% | 0.5 |
| EBIT margin | 0.0% | –1.4 PP | 1.4% |
| Additions to intangible assets and property, plant and equipment |
1.9 | +2.9% | 1.8 |
| Employees (at reporting date) | 564 | –0.5% | 567 |
| in EUR million | 1-3 2023 | Change | 1-3 2022 |
|---|---|---|---|
| Revenue | 43.0 | +52.0% | 28.3 |
| EBITDA | 7.3 | >100% | 1.3 |
| EBITDA margin | 17.0% | +12.5 PP | 4.5% |
| EBIT | 6.2 | >100% | 0.3 |
| EBIT margin | 14.4% | +13.2 PP | 1.2% |
| Additions to intangible assets and property, plant and equipment |
0.4 | +26.7% | 0.3 |
| Employees (at reporting date) | 888 | +1.6% | 874 |
| in EUR million | 1-3 2023 | Change | 1-3 2022 |
|---|---|---|---|
| Revenue | 28.8 | +9.8% | 26.2 |
| EBITDA | 5.0 | +54.3% | 3.2 |
| EBITDA margin | 17.2% | +5.0 PP | 12.2% |
| EBIT | 3.9 | +79.7% | 2.1 |
| EBIT margin | 13.4% | +5.2 PP | 8.2% |
| Additions to intangible assets and property, plant and equipment |
1.1 | –1.2% | 1.1 |
| Employees (at reporting date) | 594 | –1.9% | 605 |
Key figures Sempermed
| in EUR million | 1-3 2023 | Change | 1-3 2022 |
|---|---|---|---|
| Revenue | 39.6 | –62.7% | 106.1 |
| EBITDA | –11.6 | n/a | 13.3 |
| EBITDA margin | –29.3% | –41.9 PP | 12.6% |
| EBIT | –13.5 | n/a | 7.6 |
| EBIT margin | –34.2% | –41.4 PP | 7.2% |
| Additions to intangible assets and property, plant and equipment |
0.7 | –84.1% | 4.5 |
| Employees (at reporting date) | 2,681 | –12.2% | 3,052 |
The Medical segment is considered as a whole, without division into discontinued operations and continued operations. The following presentation therefore refers to the entire segment in total.
The headcount as of 31 March 2023 for continued and discontinued operations totalled 6,510 employees (FTE, full-time equivalent), which is –7.1% below the level of 31 March 2022 (7,007). In the Industrial Sector, the number of employees declined compared to 31 March 2022: the Semperflex, Semperform and Semperseal segments saw a decrease in employees of –6.7%, –1.9% and –0.5%, respectively. Meanwhile, the number of employees in the Sempertrans segment increased by 1.6%. The Medical Sector recorded a decrease of –12.2% compared to the previous year.
At the 134th Annual General Meeting on 25 April 2023, Thomas Cord Prinzhorn and Marion Weissenberger-Eibl were elected as new members of the Supervisory Board until the end of the Annual General Meeting which resolves on the ratification of actions for the 2025 financial year.
Claus Möhlenkamp and Klaus Erkes were re-elected as Supervisory Board members until the end of the Annual General Meeting which will decide on the discharge for the 2026 financial year.
At the constituent meeting of the Supervisory Board held after the Annual General Meeting, Thomas Cord Prinzhorn was elected Chairman of the Supervisory Board. He takes over from Stefan Fida, who has chaired the supervisory body on an interim basis since December 2022. Stefan Fida was elected Deputy Chairman of the Supervisory Board.
For the 2023 financial year, the management of the Semperit Group expects a decline in earnings from continued operations compared to the previous year. This is based on the following assumptions:
The overall economic slowdown is expected to have a noticeable impact on the Industrial Sector, especially in the second and third quarter of 2023. Inventory optimisation programmes on the part of customers already lead to restrained ordering behaviour of customers, as expected. The option to pass on potential further cost increases to customers will depend on the price sensitivity of the respective customers and the dynamics in the segment-specific product markets. As a result, lower sales volumes and increased pressure on margins are to be expected.
In addition, the earnings position of the Semperit Group may of course continue to be significantly influenced by developments such as the Russia-Ukraine conflict: The Executive Board continues to expect a high degree of volatility with regard to the price development and availability of energy in Europe but also of necessary raw materials and supplies.
Further developments in geopolitical trouble spots are still unclear and therefore uncertain. Potential negative effects of inflation and foreign currencies require a high level of attention from the Executive Board.
Against this backdrop, the Executive Board confirms the outlook for the 2023 financial year with EBITDA from continuing operations of between EUR 70 and 90 million, but from today's perspective expects the result to be at the lower end of the range.
With regard to the sale of the medical business, a first closing is expected in mid-2023 or in the following months, depending on the regulatory approval procedures currently underway.
The Medical Sector is still expected to have a negative impact on earnings after taxes. Until the closing, the negative earnings development from the medical business will affect the Semperit Group.
The management is consistently pursuing the implementation of the strategy and is focusing on organic and inorganic growth projects. In this context, the next successful step was taken: on 17 April the Semperit Group announced that it would acquire 100% of the Austrian Rico Group GmbH, a leading global supplier of silicone injection moulding tools and producer of liquid silicone components. Closing is expected in the third quarter of 2023. The long-term potential of the transaction for the Semperit Group lies primarily in high-quality tooling for high-precision and complex solutions and the automation of production steps for the manufacture of large volumes. Furthermore, the acquisition will strengthen market access to North America, where Rico has had its own production facilities for many years.
This outlook is based on the assessments of the Executive Board as of 9 May 2023 and does not take into account the impact of potential acquisitions, divestments, or other unforeseeable structural and economic changes during the remainder of 2023. These assessments are subject to both known and unknown risks and uncertainties, which may result in actual events and outcomes differing from the statements made here.
| in EUR thousand | Note | 1-3 2023 | 1-3 20221 |
|---|---|---|---|
| Revenue | 2.2 | 185,197 | 181,512 |
| Changes in inventories | 7,076 | 11,661 | |
| Own work capitalised | 562 | 581 | |
| Operating revenue | 192,834 | 193,753 | |
| Other operating income | 1,260 | 764 | |
| Cost of material and purchased services | 2.3 | –96,179 | –102,122 |
| Personnel expenses | 2.4 | –52,719 | –49,870 |
| Other operating expenses | 2.5 | –24,383 | –22,260 |
| Earnings before interest, tax, depreciation and amortisation (EBITDA) | 2.1 | 20,814 | 20,265 |
| Depreciation and amortisation of intangible assets and property, plant and equipment | –7,631 | –7,612 | |
| Earnings before interest and tax (EBIT) | 2.1 | 13,183 | 12,653 |
| Finance income | 286 | 53 | |
| Finance expenses | –584 | –731 | |
| Profit / loss attributable to redeemable non-controlling interests | –963 | –1,333 | |
| Other financial result | –687 | –29 | |
| Financial result | –1,948 | –2,041 | |
| Earnings before taxes | 11,235 | 10,612 | |
| Income taxes | –2,941 | –3,282 | |
| Earnings after tax from continued operations | 8,294 | 7,330 | |
| Earnings after tax from discontinued operations | 2.6 | –7,885 | 8,208 |
| Earnings after taxes | 409 | 15,538 | |
| thereof attributable to the shareholders of Semperit AG Holding – from ordinary shares | 510 | 15,494 | |
| thereof attributable to non-controlling interests | –101 | 45 | |
| Earnings per share in EUR (basic and diluted)2 | 0.02 | 0.75 | |
| of which earnings per share in EUR from continued operations (basic and diluted) |
0.40 | 0.36 | |
| of which earnings per share in EUR from discontinued operations (basic and diluted) |
–0.38 | 0.40 |
1The comparative figures were adjusted (see chapter 2.6).
2 Earnings per share only concern the ordinary shareholders of Semperit AG Holding.
| in EUR thousand | Note | 1-3 2023 | 1-3 2022 |
|---|---|---|---|
| Earnings after taxes | 409 | 15,538 | |
| Other comprehensive income that will not be recognised through profit and loss in future | |||
| periods | 0 | –286 | |
| Remeasurements of defined benefit plans | 0 | 0 | |
| Income tax thereon | 0 | –286 | |
| Other comprehensive income that will be recognised through profit and loss in future | |||
| periods | –732 | 5,124 | |
| Currency translation differences | –732 | 5,124 | |
| Other comprehensive income - total | –732 | 4,838 | |
| Comprehensive income | –323 | 20,376 | |
| thereof on earnings attributable to the shareholders of Semperit AG Holding – from ordinary | |||
| shares | –204 | 20,320 | |
| thereof on earnings attributable to non-controlling interests | –118 | 56 |
| in EUR thousand | Note | 1-3 2023 | 1-3 20221 |
|---|---|---|---|
| Earnings before taxes | 11,235 | 10,612 | |
| Earnings before taxes from discontinued operations² | –7,794 | 10,584 | |
| Depreciation, amortisation, impairment and reversal of impairment of intangible | |||
| assets and property, plant and equipment | 6,503 | 12,829 | |
| Gain / loss from disposal of assets (including current and non-current financial | |||
| assets) | 0 | –39 | |
| Change in non-current provisions | 2,668 | 467 | |
| Profit / loss attributable to redeemable non-controlling interests | 963 | 1,333 | |
| Net interest income (including income from securities) | 159 | 666 | |
| Income taxes paid | –4,025 | –11,614 | |
| Other non-cash income / expense | 420 | 4,802 | |
| Gross cash flow | 10,129 | 29,640 | |
| Change in inventories | 5,396 | –18,732 | |
| Change in trade receivables | –3,859 | –32,660 | |
| Change in other receivables and assets | 1,028 | 9,417 | |
| Change in trade payables | 3,713 | 24,131 | |
| Change in other liabilities and current provisions | 4,658 | 5,752 | |
| Cash flows from operating activities | 21,065 | 17,547 | |
| Proceeds from sale of property, plant and equipment | 36 | 72 | |
| Purchases of intangible assets and property, plant and equipment | –14,469 | –17,170 | |
| Interest received | 416 | 85 | |
| Investment grants received | 84 | 37 | |
| Acquisition of financial assets | 0 | –711 | |
| Cash flows from investing activities | –13,932 | –17,687 | |
| Cash receipts from current and non-current financial liabilities | –3 | –4,825 | |
| Repayment of lease liabilities | –946 | –771 | |
| Repayment of liabilities from capital repayment to non-controlling interests in | |||
| subsidiaries | 0 | –343 | |
| Interest paid | –221 | –268 | |
| Cash flows from financing activities | –1,169 | –6,206 | |
| Currency translation differences | –968 | 1,910 | |
| Net change in cash and cash equivalents | 4,996 | –4,436 | |
| Cash and cash equivalents at the beginning of the period related to continued | |||
| operations | 106,631 | 109,416 | |
| Plus cash and cash equivalents related to discontinued operations | 51,274 | 126,123 | |
| Cash and cash equivalents at the beginning of the period (consolidated | |||
| balance sheet value) | 157,906 | 235,539 | |
| Cash and cash equivalents at the end of the period | 162,902 | 231,103 | |
| Less cash and cash equivalents related to discontinued operations | 43,856 | 94,498 | |
| Cash and cash equivalents at the end of the period related to continued | |||
| operations(consolidated balance sheet value) | 119,046 | 136,605 |
1The comparative figures were adjusted (see chapter 2.6).
2 Earnings before taxes from discontinued operations comprise earnings before taxes of EUR –7,694 thousand (previous year: EUR 10,584 thousand) and transaction costs of EUR –100 thousand (previous year: EUR 0 thousand), see section 2.6.
| in EUR thousand | Note | 31.03.2023 | 31.12.2022 |
|---|---|---|---|
| Intangible assets | 5,780 | 6,283 | |
| Property, plant and equipment | 295,227 | 293,531 | |
| Other financial assets | 5,666 | 5,628 | |
| Other assets | 8,477 | 5,842 | |
| Deferred tax assets | 5,788 | 5,344 | |
| Non-current assets | 320,938 | 316,628 | |
| Inventories | 125,213 | 128,214 | |
| Trade receivables | 95,855 | 88,861 | |
| Other financial assets | 1,806 | 2,457 | |
| Other assets | 11,050 | 11,241 | |
| Current tax receivables | 239 | 1,010 | |
| Cash and cash equivalents | 119,046 | 106,631 | |
| Current assets | 353,209 | 338,414 | |
| Assets held for sale | 3 | 173,413 | 187,875 |
| ASSETS | 847,560 | 842,917 | |
| Share capital | 21,359 | 21,359 | |
| Capital reserves | 21,503 | 21,503 | |
| Retained earnings | 482,647 | 482,136 | |
| Currency translation reserve | –7,540 | –6,825 | |
| Equity attributable to the shareholders of Semperit AG Holding | 517,970 | 518,174 | |
| Non-controlling interests | 852 | 970 | |
| Equity | 518,822 | 519,145 | |
| Provisions | 32,470 | 32,134 | |
| Liabilities from redeemable non-controlling interests | 13,080 | 12,162 | |
| Financial liabilities | 37,960 | 37,956 | |
| Trade payables | 110 | 52 | |
| Other financial liabilities | 19,078 | 18,925 | |
| Other liabilities | 2,037 | 1,995 | |
| Deferred tax assets | 11,950 | 12,629 | |
| Non-current provisions and liabilities | 116,684 | 115,854 | |
| Provisions | 27,553 | 23,442 | |
| Liabilities from redeemable non-controlling interests | 6,506 | 6,745 | |
| Financial liabilities | 15,020 | 14,503 | |
| Trade payables | 62,226 | 63,890 | |
| Other financial liabilities | 12,769 | 9,553 | |
| Other liabilities | 34,774 | 35,289 | |
| Current tax liabilities | 7,656 | 7,586 | |
| Current provisions and liabilities | 166,503 | 161,009 | |
| Provisions and liabilities held for sale | 3 | 45,550 | 46,909 |
| EQUITY AND LIABILITIES | 847,560 | 842,917 |
| in EUR thousand | Note | Share capital |
Capital reserves |
Retained earnings |
Currency translation reserve |
Total | Non control ling interests |
Total equity |
|---|---|---|---|---|---|---|---|---|
| As at 01.01.2022 | 21,359 | 21,503 | 512,216 | –14,956 | 540,122 | 1,028 | 541,151 | |
| Earnings after taxes | 0 | 0 | 15,494 | 0 | 15,494 | 45 | 15,538 | |
| Other comprehensive income |
0 | 0 | –286 | 5,113 | 4,827 | 11 | 4,838 | |
| Comprehensive income | 0 | 0 | 15,208 | 5,113 | 20,320 | 56 | 20,376 | |
| As at 31.03.2022 | 21,359 | 21,503 | 527,424 | –9,844 | 560,443 | 1,084 | 561,527 | |
| As at 01.01.2023 | 21,359 | 21,503 | 482,136 | –6,824 | 518,174 | 970 | 519,145 | |
| Earnings after taxes | 0 | 0 | 510 | 0 | 510 | –101 | 409 | |
| Other comprehensive income |
0 | 0 | 0 | –715 | –715 | –17 | –732 | |
| Comprehensive income | 0 | 0 | 510 | –715 | –204 | –118 | –323 | |
| As at 31.03.2023 | 21,359 | 21,503 | 482,647 | –7,539 | 517,970 | 852 | 518,822 |
The interim group financial report has been prepared in accordance with International Financial Reporting Standards (IFRSs) and is based on the regulations for interim financial statements (IAS 34).
For more information on accounting and valuation methods of the Semperit Group, please see the consolidated financial statements as at 31 December 2022, which in this regard form the basis for this interim group financial report.
The reporting currency is the euro, with figures rounded to the nearest thousand, unless expressly stated otherwise. Rounding differences in the totalling of rounded amounts and percentages may arise from the automatic processing of data.
On 16 December 2022, the management of the Semperit Group reached an agreement with the Southeast Asian glove producer, HARPS GLOBAL PTE. LTD., which is based in Singapore and runs manufacturing operations in Malaysia, on the sale of the Sempermed segment. As far as the production of examination gloves and the associated sales organisation are concerned, the conditions for presentation as discontinued operations were given; for the time being, however, the production of surgical gloves will remain with the Semperit Group and thus will be presented in continued operations.
The interim group financial report of the Semperit Group as at 31 March 2023 have not been fully audited or reviewed by the Group's auditor
The following new/revised Standards and Interpretations were applied for the first time in the first quarter of 2023:
| Endorsement | Mandatory application for the Semperit Group |
Effects on the Semperit Group |
||
|---|---|---|---|---|
| New standards and interpretations | ||||
| IFRS 17 | Insurance Contracts | 19 November 2021 | 1 January 2023 | no |
| Amended standards | ||||
| IAS 1 | Amendments to the presentation of the financial statement: disclosure of accounting standards |
2 March 2022 | 1 January 2023 | no |
| IAS 8 | Amendments to accounting policies, amendments to accounting estimates and errors: definition of accounting estimates |
2 March 2022 | 1 January 2023 | no |
| IAS 12 | Amendments to deferred taxes related to assets and liabilities arising from a single transaction |
11 August 2022 | 1 January 2023 | no |
| Miscellan eous |
Amendments to the initial application of IFRS 17 and IFRS 9 – comparative information |
8 September 2022 | 1 January 2023 | no |
Neither the presentation nor the measurement requirements pursuant to IFRS 5 applicable to discontinued operations were used in internal segment reporting.
| 1-3 2023 in EUR thousand | Semper med |
Semper flex |
Semper trans |
Semper seal |
Semper form |
Corporate Center |
Group Elimina tions |
Total |
|---|---|---|---|---|---|---|---|---|
| Revenue | 39,572 | 72,649 | 43,018 | 31,977 | 28,793 | 0 | 0 | 216,010 |
| Revenue with other segments | 0 | 91 | 0 | 0 | 42 | 0 | –133 | 0 |
| EBITDA | –11,604 | 16,734 | 7,327 | 1,588 | 4,954 | –7,318 | 0 | 11,681 |
| EBIT | –13,544 | 13,624 | 6,191 | 6 | 3,860 | –7,675 | 0 | 2,462 |
| Depreciation and amortisation of intangible assets and property, plant and equipment |
–3,068 | –3,110 | –1,136 | –1,582 | –1,094 | –357 | 0 | –10,347 |
| Reversal of impairment of intangible assets and property, plant and equipment |
1,128 | 0 | 0 | 0 | 0 | 0 | 0 | 1,128 |
| Trade working capital | 40,026 | 73,299 | 34,081 | 25,351 | 23,030 | –6,482 | 0 | 189,306 |
| Additions to intangible assets and property, plant and equipment1 |
714 | 1,630 | 436 | 1,865 | 1,075 | 112 | 0 | 5,833 |
1 Excluding right-of-use assets in accordance with IFRS 16
| Discontinued + | |||||
|---|---|---|---|---|---|
| 1-3 2023 in EUR thousand | Total | Adjustments | continued operation |
Discontinued operation |
Continued operation |
| Revenue | 216,010 | 8,755 | 224,764 | 39,568 | 185,197 |
| Revenue with other segments | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 11,681 | 100 | 11,781 | –9,034 | 20,814 |
| EBIT | 2,462 | 2,816 | 5,277 | –7,906 | 13,183 |
| Depreciation and amortisation of intangible assets and property, plant and equipment |
–10,347 | 2,716 | –7,631 | 0 | –7,631 |
| Reversal of impairment of intangible assets and property, plant and equipment |
1,128 | 0 | 1,128 | 1,128 | 0 |
| Trade working capital | 189,306 | 0 | 189,306 | 30,464 | 158,843 |
| Additions to intangible assets and property, plant and equipment1 |
5,833 | 0 | 5,833 | 467 | 5,366 |
1 Excluding right-of-use assets in accordance with IFRS 16
| 1-3 2022 in EUR thousand | Semper med |
Semper flex |
Semper trans |
Semper seal |
Semper form |
Corporate Center |
Group Elimina tions |
Total |
|---|---|---|---|---|---|---|---|---|
| Revenue | 106,061 | 79,814 | 28,307 | 36,628 | 26,226 | 0 | 0 | 277,036 |
| Revenue with other segments | 0 | 52 | 0 | 64 | 28 | 0 | –144 | 0 |
| EBITDA | 13,327 | 19,589 | 1,273 | 2,374 | 3,210 | –3,244 | 0 | 36,531 |
| EBIT | 7,600 | 16,635 | 334 | 519 | 2,148 | –3,534 | 0 | 23,702 |
| Depreciation and amortisation of intangible assets and property, plant and equipment |
–5,727 | –2,954 | –939 | –1,855 | –1,062 | –290 | 0 | –12,829 |
| Trade working capital | 78,782 | 75,527 | 25,098 | 25,060 | 22,006 | –4,310 | 0 | 222,163 |
| Additions to intangible assets and property, plant and equipment1 |
4,492 | 1,054 | 344 | 1,813 | 1,088 | 1,206 | 0 | 9,997 |
1 Excluding right-of-use assets in accordance with IFRS 16
| Discontinued + continued |
Discontinued | Continued | |||
|---|---|---|---|---|---|
| 1-3 2022 in EUR thousand | Total | Adjustments | operation | operation | operation |
| Revenue | 277,036 | 10,530 | 287,566 | 106,054 | 181,512 |
| Revenue with other segments | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 36,531 | 0 | 36,531 | 16,266 | 20,265 |
| EBIT | 23,702 | 0 | 23,702 | 11,050 | 12,653 |
| Depreciation and amortisation of intangible assets and property, |
|||||
| plant and equipment | –12,829 | 0 | –12,829 | –5,216 | –7,612 |
| Trade working capital | 222,163 | 0 | 222,163 | 74,801 | 147,362 |
| Additions to intangible assets and property, plant and |
|||||
| equipment1 | 9,997 | 0 | 9,997 | 4,146 | 5,852 |
1 Excluding right-of-use assets in accordance with IFRS 16
| 1-3 2023 in EUR thousand | Semper med |
Semper flex |
Semper trans |
Semper seal |
Semper form |
Group |
|---|---|---|---|---|---|---|
| Western Europe | 5 | 42,625 | 18,031 | 25,506 | 17,688 | 103,856 |
| Asia | 8,755 | 5,861 | 5,677 | 95 | 5,229 | 25,617 |
| North America | 0 | 11,849 | 7,695 | 2,937 | 2,323 | 24,803 |
| Eastern Europe | 0 | 11,364 | 2,008 | 3,439 | 3,136 | 19,946 |
| Central and South America |
0 | 619 | 4,589 | 0 | 285 | 5,493 |
| Africa | 0 | 204 | 4,806 | 0 | 128 | 5,138 |
| Australia and Oceania |
0 | 127 | 212 | 0 | 4 | 343 |
| Revenue | 8,759 | 72,649 | 43,018 | 31,977 | 28,793 | 185,197 |
| 1-3 2022 in EUR thousand | Semper med |
Semper flex |
Semper trans |
Semper seal |
Semper form |
Group |
|---|---|---|---|---|---|---|
| Western Europe | 7 | 47,101 | 12,841 | 29,296 | 16,466 | 105,711 |
| Asia | 10,530 | 5,781 | 5,800 | 145 | 4,964 | 27,219 |
| North America | 0 | 9,271 | 2,382 | 2,337 | 1,244 | 15,234 |
| Eastern Europe | 0 | 15,695 | 3,390 | 4,847 | 3,110 | 27,042 |
| Central and South | ||||||
| America | 0 | 1,243 | 582 | 3 | 384 | 2,213 |
| Africa | 0 | 533 | 1,589 | 0 | 45 | 2,167 |
| Australia and | ||||||
| Oceania | 0 | 190 | 1,723 | 0 | 12 | 1,926 |
| Revenue | 10,537 | 79,814 | 28,307 | 36,628 | 26,226 | 181,512 |
| in EUR thousand | 1-3 2023 | 1-3 2022 |
|---|---|---|
| Cost of materials | 82,183 | 88,850 |
| Energy expenses | 10,382 | 9,900 |
| Production-related maintenance costs | 2,226 | 1,979 |
| Purchased services | 1,389 | 1,393 |
| Total | 96,179 | 102,122 |
| in EUR thousand | 1-3 2023 | 1-3 2022 |
|---|---|---|
| Wages | 20,170 | 19,488 |
| Salaries | 22,362 | 20,637 |
| Severance payments | 352 | 301 |
| Retirement benefit expenses | 296 | 199 |
| Statutory social security expenses and other compulsory wage-related payments | 8,828 | 8,544 |
| Other social security expenses | 709 | 701 |
| Total | 52,719 | 49,870 |
| 1-3 2023 | 1-3 2022 |
|---|---|
| 6,326 | 6,894 |
| 3,580 | 2,725 |
| 2,968 | 2,022 |
| 1,396 | 1,206 |
| 1,360 | 1,118 |
| 1,220 | 582 |
| 1,173 | 69 |
| 905 | 549 |
| 655 | 1,274 |
| 555 | 456 |
| 499 | 714 |
| 439 | 513 |
| 396 | 243 |
| 252 | 275 |
| 174 | 162 |
| 166 | 171 |
| 65 | 68 |
| –347 | 63 |
| 2,602 | 3,157 |
| 24,383 | 22,260 |
The income statement for the discontinued operations is presented below:
| in EUR thousand | 1-3 2023 | 1-3 2022 |
|---|---|---|
| Revenue | 39,568 | 106,054 |
| Changes in inventories | –277 | –8,347 |
| Own work capitalised | 19 | 410 |
| Operating revenue | 39,310 | 98,117 |
| Other operating income | 163 | 100 |
| Cost of material and purchased services | –35,976 | –62,165 |
| Personnel expenses | –7,379 | –9,051 |
| Other operating expenses | –5,152 | –10,735 |
| Earnings before interest, tax, depreciation and amortisation (EBITDA) | –9,034 | 16,266 |
| Depreciation and amortisation of intangible assets and property, plant and equipment |
0 | –5,216 |
| Reversal of impairment of intangible assets and property, plant and equipment | 1,128 | 0 |
| Earnings before interest and tax (EBIT) | –7,906 | 11,050 |
| Finance income | 100 | 38 |
| Finance expenses | –13 | –28 |
| Other financial result | 125 | –476 |
| Financial result | 212 | –466 |
| Earnings before taxes | –7,694 | 10,584 |
| Income taxes | –91 | –2,375 |
| Earnings after taxes | –7,785 | 8,208 |
| Transaction costs recognized | –100 | 0 |
| Income taxes on transactions costs recognized | 0 | 0 |
| Result from deconsolidation | 0 | 0 |
| Reclassification of other income to profit/loss for the period | 0 | 0 |
| Subtotal | –100 | 0 |
| Result from discontinued operations | –7,885 | 8,208 |
| thereof earnings attributable to the shareholders of Semperit AG | –7,784 | 8,164 |
| thereof attributable to non-controlling interests | –101 | 45 |
Earnings after taxes arising from the fair-value measurement less costs to sell correspond to the reversal of impairment losses on intangible assets and property, plant and equipment.
The expenses for material and purchased services comprise the following:
| in EUR thousand | 1-3 2023 | 1-3 2022 |
|---|---|---|
| Cost of materials | 25,462 | 49,387 |
| Energy expenses | 9,995 | 11,976 |
| Production-related maintenance costs | 456 | 721 |
| Purchased services | 62 | 81 |
| Total | 35,976 | 62,165 |
Other operating expenses comprise the following:
| in EUR thousand | 1-3 2023 | 1-3 2022 |
|---|---|---|
| Outgoing freight | 2,121 | 7,869 |
| Miscellaneous | 3,031 | 2,866 |
| Total | 5,152 | 10,735 |
| in EUR thousand | 1-3 2023 | 1-3 2022 |
|---|---|---|
| Cash flows from operating activities | –2,121 | 24,721 |
| Cash flows from investing activities | –712 | –6,582 |
| Cash flows from financing activities | –146 | –5,346 |
| in EUR thousand | 31.03.2023 | 31.12.2022 |
|---|---|---|
| Intangible assets | 100 | 99 |
| Property, plant and equipment | 75,422 | 75,328 |
| Other financial assets | 50 | 81 |
| Other assets | 10 | 24 |
| Non-current assets | 75,583 | 75,532 |
| Inventories | 35,141 | 38,597 |
| Trade receivables | 14,443 | 17,520 |
| Other financial assets | 324 | 454 |
| Other assets | 2,256 | 2,528 |
| Current tax receivables | 1,810 | 1,970 |
| Cash and cash equivalents | 43,856 | 51,274 |
| Current assets | 97,830 | 112,343 |
| Assets held for sale | 173,413 | 187,875 |
| Currency translation differences | –19,725 | –16,989 |
| Provisions | 7,024 | 4,747 |
| Other financial liabilities | 631 | 734 |
| Other liabilities | 327 | 400 |
| Deferred tax assets | 10 | 7 |
| Non-current provisions and liabilities | 7,993 | 5,887 |
| Provisions | 10,516 | 10,904 |
| Trade payables | 19,121 | 19,792 |
| Other financial liabilities | 2,026 | 2,299 |
| Other liabilities | 2,737 | 3,524 |
| Current tax liabilities | 3,157 | 4,503 |
| Current provisions and liabilities | 37,557 | 41,022 |
| Provisions and liabilities held for sale | 45,550 | 46,909 |
Am Belvedere 10 1100 Vienna, Austria Tel.: +43 1 79 777 0 Fax: +43 1 79 777 600 www.semperitgroup.com/en
Judit Helenyi Director Investor Relations Tel.: +43 1 79 777 310 www.semperitgroup.com/en/ir
www.semperitgroup.com/en/contact
Ownership and publisher: Semperit Aktiengesellschaft Holding, Am Belvedere 10, 1100 Vienna, Austria, Produced in-house with firesys GmbH, www.firesys.de
The terms "Semperit" or "Semperit Group" in this report refer to the group; "Semperit AG Holding" or "Semperit Aktiengesellschaft Holding" is used to refer to the parent company (individual company).
We have prepared this report and verified the information it contains with the greatest possible care. Nevertheless, rounding, typesetting and printing errors cannot be ruled out. Rounding of differences in the summation rounded amounts and percentages may arise from the automatic processing of data.
The forecasts, plans and forward-looking statements contained in this report are based on the knowledge and information available and the assessments made at the time that this report was prepared (editorial deadline: 09 May 2023). As is true of all forward-looking statements, these statements are subject to risk and uncertainties. As a result, actual events may deviate significantly from these expectations. No liability whatsoever is assumed for the accuracy of projections or for the achievement of planned targets or for any other forward-looking statements. Words such as "expect," "want", "believe," "anticipate," "includes," "plan," "assumes," "estimate," "projects," "intends," "should," "will," "shall," or variations of such words are generally part of forward-looking statements.
Furthermore, there is no guarantee that the contents are complete.
Statements referring to people are valid for both men and women.
This report has been written in German and English. In case of doubt, the German version shall take precedence.
| 10.08.2023 | Half-year financial report 2023 |
|---|---|
| 08.11.2023 | Report on Q1-3 2023 |
Have a question? We'll get back to you promptly.